...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why have we not heard more about CURATE-AI?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

narmac, I guess they're no longer a mention of using CURATE.AI-suggested dosing of ZEN-3694 and enzalutamide.

 

Koo

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply